47
Participants
Start Date
March 16, 2023
Primary Completion Date
January 22, 2025
Study Completion Date
January 22, 2025
ruxolitinib cream
ruxolitinib cream 1.5% will be applied twice daily as a thin film
Sadick Dermatology, New York
Suny Downstate Health Sciences University, Brooklyn
Empire Dermatology, East Syracuse
Skin Search of Rochester, Rochester
University of Pittsburgh, Pittsburgh
Gw Training Center, Washington D.C.
Pi Coor Clinical Research Llc, Burke
Clinical Research Partners Llc, Richmond
Clinical Research Center of the Carolinas, Charleston
University of Florida Health Dermatology-Springhill, Gainesville
Skin Care Research, Llc Scr Hollywood, Hollywood
Driven Research Llc, Coral Gables
Ciocca Dermatology Pa, Miami
Skin Care Research, Llc, Boca Raton
Trueblue Clinical Research, Tampa
Skin Sciences Pllc, Louisville
Ohio Pediatric Research Association, Dayton
Dawes Fretzin Clinical Research Group Llc, Indianapolis
Dermatology Specialists Research Indiana, Clarksville
Washington University School of Medicine Dermatology, St Louis
Arlington Research Center, Arlington
Jordan Valley Dermatology Center, South Jordan
Ark Clinical Research, Long Beach
First Oc Dermatology, Fountain Valley
Oregon Dermatology and Research Center, Portland
Knight Cancer Institute At Oregon Health and Science University, Portland
Dermatology Specialists of Spokane, Spokane
Beth Israel Deaconess Medical Center (Bidmc), Boston
Northeast Dermatology Associates, Methuen
Essential Dermatology, Natick
Lead Sponsor
Incyte Corporation
INDUSTRY